Fresenius Medical Care AG – Filings and Transcripts

NYSE: FMS
Share price (8/17/26): $23.50
Market cap (8/17/26): $13.1 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

Prospectuses and Registrations Filter

Amendment to registration of securities for employees

Removal from listing

Prospectus supplement

Business combination disclosure

Business combination disclosure

Ownership Filter

Annual report of employee stock purchase, savings and similar

Renkewitsch Olga

News Filter

Material disclosure

Appoints Cassie McLean as New Management Board Member for Care Delivery

Accelerates Income Growth to 23% in the Second Quarter of 2026 While Advancing Its Strategic Agenda

HEADLINE: Fresenius Medical Care Reports Operating Income Excluding Special Items to Be Above Market Expectations in the Second Quarter of 2026 and Confirms Its Outlook for the Financial Year 2026

Announces BEACON-US, Generating Real-World Evidence Supporting High-Volume Hemodiafiltration for U.S. Dialysis Patients

Proxies

No filings in this category.

Other Filter

Conflict Minerals disclosure

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012

Conflict Minerals disclosure

Notice required by Iran Threat Reduction and Syria Human Rights Act of 2012

Conflict Minerals disclosure